Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

No comments:

Post a Comment

< + > Bonus Features – September 21, 2025 – 19% of cyberattacks cost healthcare orgs at least $200,000, only 49% of healthcare leaders think AI will solve their cost efficiency problems, plus 26 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...